Loading…
Based on limited available metadata, the FDA issued a warning letter to Dong Yuan Technology Co., Ltd., a pharmaceutical company, on March 18, 2019. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the metadata provided. The warning relates to drug manufacturing or distribution practices subject to FDA oversight. To understand the specific compliance issues cited, the complete warning letter would need to be reviewed.